Public Profile

Biontech

BioNTech SE, headquartered in Mainz, Germany, is a pioneering biotechnology company renowned for its innovative approach to immunotherapy. Founded in 2008, BioNTech has rapidly established itself as a leader in the development of personalised cancer treatments and infectious disease vaccines, notably its groundbreaking mRNA technology. The company gained global recognition for its collaboration with Pfizer in creating one of the first COVID-19 vaccines, marking a significant milestone in the fight against the pandemic. BioNTech's core offerings include mRNA-based therapeutics and vaccines, which are distinguished by their ability to elicit robust immune responses. With a strong market position and a commitment to advancing medical science, BioNTech continues to push the boundaries of biotechnology, aiming to transform patient care worldwide.

DitchCarbon Score

How does Biontech's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

33

Industry Average

Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

24

Industry Benchmark

Biontech's score of 33 is higher than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.

92%

Biontech's reported carbon emissions

In 2023, BioNTech reported total carbon emissions of approximately 534,182,000 kg CO2e. This figure includes 1,342,000 kg CO2e from Scope 1 emissions, which encompass direct emissions from owned or controlled sources, and 3,339,000 kg CO2e from Scope 2 emissions, related to indirect emissions from the generation of purchased electricity, steam, heating, and cooling. Additionally, the company’s Scope 3 emissions, which cover all other indirect emissions, amounted to approximately 529,501,000 kg CO2e. Comparatively, in 2022, BioNTech's total emissions were about 1,120,551,000 kg CO2e, indicating a significant reduction in emissions year-on-year. The company has set ambitious climate commitments, aiming to reduce its absolute Scope 1 and 2 greenhouse gas emissions by 42% by 2030, using 2021 as the base year. Furthermore, BioNTech is committed to ensuring that 72% of its suppliers, based on emissions from purchased goods and services, capital goods, and upstream transportation and distribution, will have science-based targets by 2027. These targets align with the Science Based Targets initiative (SBTi) and are designed to contribute to limiting global warming to 1.5°C, reflecting BioNTech's commitment to sustainability and climate action within the pharmaceutical and biotechnology sector.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20192020202120222023
Scope 1
607,000
000,000
000,000
000,000
0,000,000
Scope 2
2,748,000
0,000,000
0,000,000
0,000,000
0,000,000
Scope 3
2,445,000
0,000,000
0,000,000,000
0,000,000,000
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Biontech's primary industry is Research and development services (73), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Biontech is headquartered in DE, which has a rank of medium, indicating medium grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Biontech is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

Astra Zeneca

GB
Chemicals nec
Updated 3 days ago

Glaxosmithkline

GB
Medical, precision and optical instruments, watches and clocks (33)
Updated 3 days ago

VBI Vaccines Inc.

US
Health and social work services (85)
Updated 3 days ago

Janssen

US
Health and social work services (85)
Updated 27 days ago

Johnson And Johnson

US
Chemicals nec
Updated 3 days ago

Dynavax Technologies Corporation

US
Health and social work services (85)
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers